CA2323526A1 - Formulation contenant une proteine specifique des papillomavirus, sa fabrication et son utilisation - Google Patents

Formulation contenant une proteine specifique des papillomavirus, sa fabrication et son utilisation Download PDF

Info

Publication number
CA2323526A1
CA2323526A1 CA002323526A CA2323526A CA2323526A1 CA 2323526 A1 CA2323526 A1 CA 2323526A1 CA 002323526 A CA002323526 A CA 002323526A CA 2323526 A CA2323526 A CA 2323526A CA 2323526 A1 CA2323526 A1 CA 2323526A1
Authority
CA
Canada
Prior art keywords
protein
hpv
formulation according
formulation
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002323526A
Other languages
English (en)
Inventor
Alexander Burger
Josef Gabelsberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medigene AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2323526A1 publication Critical patent/CA2323526A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne une formulation qui contient au moins une protéine spécifique des papillomavirus et environ 0,3 à 4 M d'un sel à un pH compris entre 7,3 et 7,45 environ.
CA002323526A 1998-03-24 1999-03-24 Formulation contenant une proteine specifique des papillomavirus, sa fabrication et son utilisation Abandoned CA2323526A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19812940.8 1998-03-24
DE19812940A DE19812940A1 (de) 1998-03-24 1998-03-24 Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung
PCT/EP1999/001999 WO1999048917A2 (fr) 1998-03-24 1999-03-24 Formulation contenant une proteine specifique des papillomavirus, sa fabrication et son utilisation

Publications (1)

Publication Number Publication Date
CA2323526A1 true CA2323526A1 (fr) 1999-09-30

Family

ID=7862147

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002323526A Abandoned CA2323526A1 (fr) 1998-03-24 1999-03-24 Formulation contenant une proteine specifique des papillomavirus, sa fabrication et son utilisation

Country Status (8)

Country Link
EP (1) EP1066321A2 (fr)
JP (1) JP2002507625A (fr)
AR (1) AR014969A1 (fr)
AU (1) AU3598999A (fr)
CA (1) CA2323526A1 (fr)
DE (1) DE19812940A1 (fr)
MX (1) MXPA00009283A (fr)
WO (1) WO1999048917A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1213299A1 (fr) * 2000-12-08 2002-06-12 Leids Universitair Medisch Centrum Epitopes immunogènes du papillomavirus humains et leurs usages
EP1355925A2 (fr) * 2000-12-08 2003-10-29 Academisch Ziekenhuis Leiden Peptides longs de 22-45 residus d'acides amines induisant et/ou stimulant les reponses immunitaires specifiques de l'antigene
AU2002219711B8 (en) 2000-12-08 2006-03-02 Academisch Ziekenhuis Leiden Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
US7901921B2 (en) * 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915794A (en) * 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
SE9001705D0 (sv) * 1990-05-11 1990-05-11 Medscand Ab Saett foer diagnostik av virusbaerande tumoerer genom immunoassay
DE4447664C2 (de) * 1994-10-07 1999-04-15 Lutz Prof Dr Gissmann Fusionsproteine, Verfahren zu deren Herstellung sowie deren Anwendung
CA2202090C (fr) * 1994-10-07 2012-04-17 Lutz Gissmann Particules semblables au virus du papillome, proteines de fusion et leur procede de production

Also Published As

Publication number Publication date
AU3598999A (en) 1999-10-18
MXPA00009283A (es) 2002-12-13
DE19812940A1 (de) 1999-10-07
WO1999048917A2 (fr) 1999-09-30
EP1066321A2 (fr) 2001-01-10
AR014969A1 (es) 2001-04-11
JP2002507625A (ja) 2002-03-12
WO1999048917A3 (fr) 1999-12-09

Similar Documents

Publication Publication Date Title
US6228368B1 (en) Papilloma virus capsomere formulations and method of use
EP1305039B1 (fr) Formes (fixes) stables de proteines l1 virales capsidiales et de proteines virales capsidiales hybrides et leurs utilisations
US6352696B1 (en) Papillomavirus truncated L1 protein and fusion protein constructs
US6649167B2 (en) Papillomavirus truncated L1 protein and fusion protein constructs
US6991795B1 (en) Protein delivery system using human papillomavirus virus-like particles
AU753391B2 (en) Protein delivery system using human papillomavirus virus-like particles
US7182947B2 (en) Papillomavirus truncated L1 protein and fusion protein constructs
CA2323526A1 (fr) Formulation contenant une proteine specifique des papillomavirus, sa fabrication et son utilisation
AU755242B2 (en) Medicament for preventing or treating papilloma virus-specific tumors
US6926897B1 (en) Medicament for the avoidance or treatment of papillomavirus-specific tumour
US7494658B2 (en) Papilloma virus truncated L1 protein and fusion protein constructs
MXPA00003358A (en) Papilloma virus capsomere vaccine formulations and methods of use
DE29824556U1 (de) Formulierung mit Papillomavirus-spezifischem Protein
AU4447999A (en) Chimeric papillomavirus-like particles

Legal Events

Date Code Title Description
FZDE Dead